Metraipolis › archive › dc_85e9dc02c809

Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery — Europe PMC PMID:41155989

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155989
DOI
10.3390/pharmaceutics17101354
License (as archived)
solo-consultazione
Archived
2026-11-09T04:53:25.524Z
SHA-256 of the archived text
ce39ac3ee3c55105e8f40f33fc391ba4ab1744210f8ea0613d9a177f1633260d
Stable URL of this page
https://metraipolis.com/documento/dc_85e9dc02c809

How to cite

Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery — Europe PMC PMID:41155989 — Europe PMC (en), https://europepmc.org/article/MED/41155989 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_85e9dc02c809 (Metraipolis archive dc_85e9dc02c809, sha256 ce39ac3ee3c55105e8f40f33fc391ba4ab1744210f8ea0613d9a177f1633260d)
BibTeX
@misc{dc85e9dc02c809,
  title = {Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery — Europe PMC PMID:41155989},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155989},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_85e9dc02c809; sha256 ce39ac3ee3c55105e8f40f33fc391ba4ab1744210f8ea0613d9a177f1633260d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155989. Agents can read the archived copy with the MCP tool read_document.